BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock) - Net Long/Short Value

Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock)
US ˙ NasdaqGM ˙ US91864C1071

BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock) - Net Long/Short Value
Denne side viser netto-lange/korte værdiansættelser for hver institutionel besiddelse, der er rapporteret via 13F- eller NPORT-ansøgninger. For at beregne netto lang/kort værdi tilføjer vi egenkapitalværdien til værdien af call-optionen og trækker put-optionsværdien fra. Fonde, der rapporterer korte lånte positioner, vil rapportere aktieværdier som negative. Lange nettopositioner vil have positive tal i kolonnen netto lange/korte, og korte nettopositioner vil have negative værdier i denne kolonne.
Ejer Egenkapitalværdi
($1000)
Opkaldsværdi
($1000)
Sæt værdi
($1000)
Netto Lang/Kort
($1000)
DC Funds, LP
SC CHINA HOLDING Ltd
Geode Capital Management, Llc
Renaissance Technologies Llc
Janney Montgomery Scott LLC
Morgan Stanley
Johns Hopkins University
HighTower Advisors, LLC
New England Capital Financial Advisors LLC
Gilead Sciences Inc
Alphabet Inc.
Citadel Advisors Llc
FNCMX - FIDELITY CONCORD STREET TRUST - Fidelity Nasdaq Composite Index Fund
Baird Financial Group, Inc.
M&G Plc
Other Listings
DE:2AB 0,92 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista